tiprankstipranks
The Fly

Fulgent Genetics price target lowered to $45 from $50 at Credit Suisse

Fulgent Genetics price target lowered to $45 from $50 at Credit Suisse

Credit Suisse lowered the firm’s price target on Fulgent Genetics to $45 from $50 following quarterly results. The firm keeps an Outperform rating on the shares as it believes the company is poised to gain share in the genetic and oncology testing markets due to synergies from its recent acquisitions and disruptions at competitors.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on FLGT:

Questions or Comments about the article? Write to editor@tipranks.com